ING Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,000
Closed -$683K 874
2019
Q1
$683K Buy
+6,000
New +$441K 0.01% 385

Other funds holding ONCE

ING Group's ONCE Position: Q2 2019 in Review

ING Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 6,000 shares — an estimated $683K sold.

ING Group first reported a position in ONCE in Q1 2019 and held it in 1 quarter. The position peaked at $683K in Q1 2019. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • ING Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • ING Group sold 6,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $683K.
  • ING Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • ING Group's Spark Therapeutics, Inc. Common Stock position peaked at $683K in Q1 2019.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on ING Group's 13F filing for Q2 2019, filed 12 Aug 2019.